Effects of Kinesio Taping Application in Women With Overactive Bladder

Not Applicable

• Conditions: Overactive Bladder Syndrome
• Interventions: Other: Sham tape application; Other: Kinesio tape application

• Registration Number: NCT03817203
• Lead Sponsor: Ataturk Training and Research Hospital

Brief Summary

The aim of this study is to compare the effects of kinesio tape application on bladder symptoms and quality of life in women with overactive bladder (OAB).

Detailed Description

Not available

Study Timeline

• Study Start: 2018-11-15
• Status Verified: 2019-01
• Study First Submitted: 2019-01-20
• Study First Submitted QC: 2019-01-24
• Last Update Submitted: 2019-01-24
• Study First Posted: 2019-01-25
• Last Update Posted: 2019-01-25
• Primary Completion: 2019-06
• Study Completion: 2019-08

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

• 20 to 65 years of age,
• having overactive bladder
• being volunteer

Exclusion Criteria

• pregnancy,
• only stress incontinence,
• the presence of a malignant condition with a history of acute infection,
• having a mental problem to prevent co-morbidity, evaluation and cooperative

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Arm && Interventions

Group	Intervention	Description
Control group	Sham tape application	Sham kinesio tape application and pelvic floor exercise have been applied
Kinesio tape group	Kinesio tape application	Kinesio tape application and pelvic floor exercise have been applied

Primary Outcome Measures

Name	Time	Method
The severity of overactive bladder symptoms assessed with Overactive Bladder Questionnaire_V8	Change from baseline bladder symptoms at 6 weeks	Overactive Bladder Questionnaire_V8 assessing severity of overactive bladder symptoms will be used. This scale includes items on urgency, incontinence, nocturia and voiding frequency, as defined by the International Continence Society, referring to the previous four weeks.; Overactive Bladder Questionnaire_V8 assessing severity of overactive bladder symptoms will be used. This scale includes items on urgency, incontinence, nocturia and voiding frequency, as defined by the International Continence Society. The final score is the sum of the partial scores obtained for each of the eight questions, ranging from 0 to 40.

Secondary Outcome Measures

Name	Time	Method
Urgency complaint assessed with the Perception of Intensity of Urgency Scale	Change from baseline urgency complaints at 6 weeks	The patient's Perception of Intensity of Urgency Scale assessing urgency complaints will be used. This scale is scored on 0 and 4 points (the best score is '0' and the worst score is '4') based on urgency complaints. Higher scores indicate more severe urgency complaints.
Daily urinary frequency measured with voiding diary	Change from baseline the average daily urinary frequency at 6 weeks	Patients will be also instructed to keep voiding diary for three days. In this diary, the average daily urinary frequency will be recorded.
The number of nocturia measured with voiding diary	Change from baseline the average number of nocturia at 6 weeks	Patients will be also instructed to keep voiding diary for three days. In this diary, the average number of nocturia will be recorded.
pelvic floor muscle strength measured with Modified Oxford Grading scale	Change from baseline pelvic floor muscle strength at 6 weeks	The modified Oxford Grading Scale quantifies pelvic floor muscle strength as: 0, no contraction; 1, flicker; 2, weak; 3, moderate; 4, good; and 5, strong.
The number of urinary incontinence measured with voiding diary	Change from baseline the average number of urinary incontinence at 6 weeks	Patients will be also instructed to keep voiding diary for three days. In this diary, the average number of urinary incontinence will be recorded.
quality of life assessed with King's Health Questionnaire (KHQ)	Change from baseline quality of life at 6 weeks	King's Health Questionnaire assessing quality of life related to urinary problems will be used. This questionnaire consists of two parts and 32 items. The first part (21 items) contains two single-item questions that address General Health Perception and Incontinence Impact and the following seven multi-item domains: Role, Physical, and Social Limitations, Limitations in Personal Relationship, Emotional Problems, Sleep and Energy Disturbances associated with UI, and Severity Measures for UI. The second part has an 11-item Symptom Severity Scale (SSS) that assesses the presence and severity of urinary symptoms. While the entire SSS is scored from 0 (best) to 30 (worst), the minimum possible score is 0 (best health) and the maximum possible score is 100 (worst health) for all other KHQ domains.

Trial Locations

Locations (1)

Ankara Gazi Mustafa Kemal Hospital; 🇹🇷 Ankara, Turkey